MDGL- Madrigal Pharmaceuticals, Inc.

Name: Madrigal Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Madrigal Pharmaceuticals, Inc. (MDGL) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 92 sells. MDGL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Taub Rebecca	452.2K	$228.71M	-
Dir	Friedman Paul A	199.7K	$100.98M	-
Dir	Baker Bros. Advisors LP	199.7K	$100.98M	-
CEO	Sibold William John	150.1K	$75.90M	-
Dir	Levy Richard S	27.3K	$13.83M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 1, 2026	Soergel David	Chief Medical Officer	Sell	1,042	$495.74	$516,561.08	-9.4%	-	-
May 22, 2026	Levy Richard S	Director	Sell	5,682	$515.44	$2,928,716.43	-1.8%	-	-
Mar 6, 2026	Taub Rebecca	Director	Sell	491	$431.94	$212,082.54	-0.1%	+11.1%	-
Mar 6, 2026	Huntsman Carole	Chief Commercial Officer	Sell	419	$431.94	$180,982.86	-3.2%	+11.1%	-
Jan 9, 2026	Friedman Paul A	Director	Sale+OE	24,520	$522.39	$12,808,956.93	-0.4%	+2.0%	-
Jan 9, 2026	Taub Rebecca	Director	Sale+OE	18,410	$522.40	$9,617,312.08	-0.1%	+2.0%	-
Jan 9, 2026	Taub Rebecca	Director	Sale+OE	240	$550.33	$132,080.00	-	+2.0%	-
Jan 9, 2026	Friedman Paul A	Director	Sale+OE	280	$551.24	$154,347.59	-0.1%	+2.0%	-
Dec 10, 2025	Taub Rebecca	Director	Sale+OE	18,650	$552.15	$10,297,572.90	-0.4%	-21.7%	-
Dec 10, 2025	Friedman Paul A	Director	Sale+OE	24,800	$552.18	$13,694,157.83	-1.4%	-21.7%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC